Dr. Mead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1275 York Ave
New York, NY 10065Phone+1 212-639-6673Fax+1 718-920-2058
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Pulmonary Disease and Critical Care Medicine, 2007 - 2010
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Residency, Internal Medicine, 2003 - 2006
- University of Massachusetts Medical SchoolClass of 2003
Certifications & Licensure
- NY State Medical License 2006 - 2026
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 1 citationsPoint-of-care Ultrasound (POCUS) Program for Critical Care Nurse Practitioners and Physician Assistants in an Oncological Intensive Care Unit and Rapid Response Team.Leon L Chen, Kate Tayban, Joanna Tomicich, Tara Buchholz, Melissa Barzola
Journal of the American Association of Nurse Practitioners. 2023-08-30 - 49 citationsCD19 CAR T-cell therapy and prophylactic anakinra in relapsed or refractory lymphoma: phase 2 trial interim results.Jae H Park, Karthik Nath, Sean M Devlin, Craig S Sauter, M Lia Palomba
Nature Medicine. 2023-07-01 - 18 citationsBiomarkers and cardiovascular outcomes in chimeric antigen receptor T-cell therapy recipients.Syed S Mahmood, Peter A Riedell, Stephanie Feldman, Gina George, Stephen A Sansoterra
European Heart Journal. 2023-06-09
Abstracts/Posters
- Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T CellsElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Comparing Gradings of Immune Effector Cells Toxicities: Application of Astct Consensus Grading System and Implications for Clinical ManagementElena Mead, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: